Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0036341 (schizophrenia)
 60,220 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The transmethylation hypothesis of schizophrenia was reviewed with considerations that large doses of methionine when combined with a monoamine oxidase inhibitor lead to exacerbation of psychotic symptoms in a significant percentage of chronic schizophrenic patients. It was noted that nicotinic acid in the dosage of 3,000 mg/day can neither prevent nor counteract the psychopathology thus induced.
 ...
PMID:Transmethylation hypothesis of schizophrenia: methionine and nicotinic acid. 33 34

A total of sixty patients were trated with bromperidol first in open conditions (20 patients), then on a double blind basis (40 patients) with haloperidol as the reference substance. The open study lasted for four weeks; the drug was administrated in the form of 1 mg tablets. The daily dose (initial dose: 1 mg; mean dose at the end of the trial: 4.47 mg) was always administered in one single dose. Nineteen patients finished the trial, and in 18 cases the therapeutic result was considered very good to good. These results were confirmed by statistical analysis. Nine patients exhibited mild to moderate extrapyramidal concomitant symptoms; no other side effects were observed. The results of detailed laboratory tests and evaluations of various quantitative and qualitative tolerability parameters were not indicative of toxic effects. In the double blind study with haloperidol, both substances were found to be highly effective in the treatment of psychotic syndromes belonging predominantly to the schizophrenia group. Certain clues, including the onset of action, seem to be indicative of the superiority of bromperidol. No differences were observed with respect to side effects and general tolerability.
 ...
PMID:Clinical experiences in an open and a double-blind trial. 34 84

A study of the historical development of nosological conceptions of schizophrenia of children in parallel with the development of pedopsychiatry shows that these conceptions closely follow the lines of adult psychiatry. The description of psychosis-like conditions such as infantile dementia and autism also did not yet lead to a fundamental change in pathogenetic conceptions. There is then described the heuristic approach to considering schizophrenia of children and schizophrenia-like pictures of childhood as a disturbance of adaptation to reality, the development of which can be due to dispositional factors, minimal cerebral lesions acquired in early childhood, and environmental conditions in the sense of a constellatory genesis.
 ...
PMID:[Development of nosological conceptions of child psychoses]. 35 60

Present clinical and research methods of differential diagnosis of schizophrenia and affective psychoses rely very heavily on presenting symptoms and signs, especially in acute psychosis. We have reviewed studies bearing on this issue, including studies of the phenomenology of psychotic illness, outcome, family history, response to treatment with lithium carbonate, and cross-national and historical diagnostic comparisons. We conclude that most so-called schizophrenic symptoms, taken alone and in cross section, have remarkably little, if any, demonstrated validity in determining diagnosis, prognosis, or treatment response in psychosis. In the United States, particularly, overreliance on such symptoms alone results in overdiagnosis of schizophrenia and underdiagnosis of affective illnesses, particularly mania. This compromises both clinical treatment and research.
 ...
PMID:Diagnosis in schizophrenia and manic-depressive illness: a reassessment of the specificity of 'schizophrenic' symptoms in the light of current research. 35 52

Dopamine and its specific receptors are widely distributed in man. Body regions where dopaminergic activity is of special pharmacologic interest include the basal ganglions, hypothalamus, chemoreceptor trigger zone, other less well defined areas in the central nervous system, and the renal and cardiovascular systems. The search for dopaminergic agents to modify these systems in disease states has depended heavily on in vitro and in vivo bioassays. These assays involving receptor binding, enzyme activation, smooth muscle and neuronal excitation, and modification of animal behavior have provided physicians with important therapeutic tools. Indeed, the introduction of levodopa for the treatment of Parkinson's disease and of the phenothiazines and related drugs for schizophrenia and psychosis has been a hallmark of neuropharmacologic research. However, the maximal benefits that these drugs may afford have not yet been realized due to an inadequate understanding of disease processes and a relative lack of specificity of drug action.
 ...
PMID:Clinical aspects of dopamine agonists and antagonists. 35 76

A double-blind, randomized, multicentre trial was carried out in 47 psychotic patients to evaluate the efficacy of oral treatment with loxapine compared with perphenazine. In total, 22 patients were included in diagnostic Group I (cases of acute schizophrenia and psychogenic (reactive) psychoses). The average maximum daily dose was 60.0 mg in the loxapine group and 36.8 mg in the perphenazine group. After 3-weeks' treatment, no significant differences were found between the two treatment groups according to the Brief Psychiatric Rating Scale (BPRS), Clinical Global Impression (CGI) Scale or side-effect records. Twenty-five patients were included in diagnostic Group II (cases of chronic schizophrenia). The average daily dosage was 81.1 mg in the loxapine group and 90.1 mg in the perphenazine group. After 10 to 12-weeks' treatment, no significant differences between the two treatment groups could be found according to BPRS, CGI scale, Nurses' Observation Scale for In-patient Evaluation (NOSIE) or side-effect records. The diastolic blood pressure (lying and standing) tended to increase slightly in both treatment groups. In conclusion, it was found that loxapine and perphenazine seemed to be equally effective and, based on experience with parenteral loxapine treatment, it is suggested that further investigation of oral loxapine should be carried out in psychotic patients in whom agitation is a feature.
 ...
PMID:Loxapine versus perphenazine in psychotic patients. A double-blind, randomized, multicentre trial. 36 45

Current evidence on the role of viruses in the causation of psychiatric illness is reviewed. Herpes simplex encephalitis is relatively well defined but a wider role for this virus, particularly in relation to affective disorders, is suggested by some Scandinavian surveys of antibody titres in psychiatric populations. The extent to which influenzal illnesses and infectious mononucleosis may lead to neurotic, and occasional psychotic, episodes is the subject of controversy. The clinical literature is reviewed on the occurrence of encephalitis-like illnesses with prominent psychiatric and behavioural features. It is pointed out that no reliable criterion exists for differentiating these illnesses from such psychiatric syndromes as schizophrenia. It is suggested that neglect of this borderland area, and perhaps preconceptions concerning the features of 'organic' and 'functional' psychiatric disease, may have led to an underestimate of the possible role of viruses in the causation of psychiatric disease.
 ...
PMID:Viral causes of psychiatric disease. 37 Aug 11

Retaining an individual on psychiatric dispensary lists long after a single psychotic episode can result in unnecessary restriction of his or her social-vocational rights and responsibilities. This study demonstrates that an early clinical differention can be made between exogenous psychoses and progressive schizophrenia. The validity of the clinical differentiation was enhanced by demonstrating that a computer learning and pattern-recognition program was capable of using signs and symptoms recorded in the first psychotic episode to make a differential diagnosis that coincided closely with diagnoses made at a later date by clinicians aware of the subsequent clinical course. This kind of approach to standardized nosologic principles may expand the possibility for more appropriate application of psychotropic medications, psychotherapy, and somatic treatments, as well as more accurate social-vocational prognoses.
 ...
PMID:Differentiating exogenous psychiatric illness from schizophrenia. 37 60

Production of a leukocyte migration inhibition factor by peripheral blood lymphocytes in response to challenge with gluten fractions was studied in hospitalized patients with schizophrenia and other psychoses compared with normal individuals and with children and adolescents with celiac disease. The schizophrenic and other psychotic patients could be subdivided into two groups, one that responded in the leukocyte migration inhibition factor test as the celiac patients did and one that responded as the normal control subjects did. The psychotic and schizophrenic patients did not show any evidence of malabsorption. The authors speculate that gluten may be involved in biological processes in the brain in certain psychotic individuals.
 ...
PMID:Immunologic reaction of psychotic patients to fractions of gluten. 38 9

The results of the qualitative but particularly the quantitative EEG-studies indicate that 1. The EEG of adult schizophrenics is characterized by an appearance of excessive fast activity along with some slow waves and the lack of alpha-activity. 2. Excessive fast activity and lack of alpha-waves have also been found in the EEGs of psychotic children and most interestingly in children whose parents (particularly the mother) are schizophrenic (high risk children). 3. Based on the studies during sleep and investigations with neuroleptics, it was established that the origin of the excess fast activity in schizophrenia cannot be the muscle potential. Particularly the excess fast activity in high risk children for schizophrenia goes against the muscle potential hypothesis. 4. The quantitative EEG changes seen in schizophrenia show similarity to those seen after hallucinogenic compounds particularly after anticholinergic hallucinogenics. 5. All neuroleptics (major tranquilizers) produce quantitative EEG alterations which are almost diametrically opposite to those seen in schizoprenia.
 ...
PMID:[Qualitative and quantitative EEG-findings in schizophrenia (author's transl)]. 41 42


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>